DHG Pharmaceutical JSC Market Cap ($409.82 Million)
Market Cap & Net Worth: DHG Pharmaceutical JSC (DHG)
DHG Pharmaceutical JSC market cap. DHG Pharmaceutical JSC (VN:DHG) has a market capitalization of $409.82 Million (₫10.79 Trillion) as of November 6, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #12975 globally and #62 in its home market, demonstrating a -5.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DHG Pharmaceutical JSC's stock price ₫82500.00 by its total outstanding shares 130746071 (130.75 Million). Also see how efficiently does DHG Pharmaceutical JSC generate cash for how efficiently the company converts equity into cash flow.
DHG Pharmaceutical JSC Market Cap History (2015–2026)
DHG Pharmaceutical JSC market cap history from 2015 to 2026. Data shows growth from $157.41 Million to $409.82 Million (8.82% CAGR). Check DHG Pharmaceutical JSC share price for real-time trading data and today's change.
DHG Pharmaceutical JSC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DHG Pharmaceutical JSC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of DHG Pharmaceutical JSC to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.00x
DHG Pharmaceutical JSC's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
DHG Pharmaceutical JSC's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $368.23 Million | $3.90 Trillion | $635.39 Billion | 0.00x | 0.00x |
| 2020 | $436.69 Million | $3.76 Trillion | $739.87 Billion | 0.00x | 0.00x |
| 2021 | $493.75 Million | $4.00 Trillion | $777.22 Billion | 0.00x | 0.00x |
| 2022 | $383.02 Million | $4.68 Trillion | $988.45 Billion | 0.00x | 0.00x |
| 2023 | $484.06 Million | $5.02 Trillion | $1.05 Trillion | 0.00x | 0.00x |
| 2024 | $516.13 Million | $4.88 Trillion | $778.92 Billion | 0.00x | 0.00x |
| 2025 | $508.18 Million | $5.27 Trillion | $852.35 Billion | 0.00x | 0.00x |
Competitor Companies of DHG by Market Capitalization
Companies near DHG Pharmaceutical JSC in the global market cap rankings as of November 6, 2026. Also see DHG Pharmaceutical JSC asset portfolio for a full breakdown of the balance sheet.
Key companies related to DHG Pharmaceutical JSC by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #506 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #532 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #570 globally with a market cap of $46.85 Billion USD ( CN¥320.16 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #506 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #532 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.40 |
| #570 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.85 Billion | CN¥50.19 |
| #615 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €19.30 |
Market Capitalization of DHG Pharmaceutical JSC (2015–2026)
Market capitalization of DHG Pharmaceutical JSC from 2015 to today. Between 2015 and today, DHG Pharmaceutical JSC's market cap moved from $157.41 Million to $ 409.82 Million, with a yearly change of 8.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫409.82 Million | -19.35% |
| 2025 | ₫508.18 Million | -1.54% |
| 2024 | ₫516.13 Million | +6.62% |
| 2023 | ₫484.06 Million | +26.38% |
| 2022 | ₫383.02 Million | -22.43% |
| 2021 | ₫493.75 Million | +13.07% |
| 2020 | ₫436.69 Million | +18.59% |
| 2019 | ₫368.23 Million | +18.37% |
| 2018 | ₫311.08 Million | -30.30% |
| 2017 | ₫446.31 Million | +84.48% |
| 2016 | ₫241.93 Million | +53.70% |
| 2015 | ₫157.41 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 6th, 2026 the market cap of DHG Pharmaceutical JSC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $409.82 Million USD |
| MoneyControl | $409.82 Million USD |
| MarketWatch | $409.82 Million USD |
| marketcap.company | $409.82 Million USD |
| Reuters | $409.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and … Read more